Prostate stem cell antigen gene is expressed in islets of pancreas.
10.5115/acb.2012.45.3.149
- Author:
Hiroe ONO
1
;
Kazuyoshi YANAGIHARA
;
Hiromi SAKAMOTO
;
Teruhiko YOSHIDA
;
Norihisa SAEKI
Author Information
1. Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan. nsaeki@ncc.go.jp
- Publication Type:Original Article
- Keywords:
GPI-anchored protein;
Islet cells;
Pancreatic cancer;
Splicing variant;
Immunohistochemistry
- MeSH:
Antigens, Surface;
Cell Line;
Gallbladder Neoplasms;
Glucagon;
Immunohistochemistry;
Insulin;
Islets of Langerhans;
Methylation;
Pancreas;
Pancreatic Neoplasms;
Pancreatic Polypeptide;
Prostate;
Prostatic Neoplasms;
RNA, Messenger;
Somatostatin;
Stem Cells;
Stomach Neoplasms;
Transcription Initiation Site
- From:Anatomy & Cell Biology
2012;45(3):149-154
- CountryRepublic of Korea
- Language:English
-
Abstract:
Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol-anchored cell surface antigen with an organ-dependent expression pattern in cancers; e.g., up-regulated in prostate cancer and down-regulated in gastric cancer. Previously it was reported that PSCA is not expressed in the normal pancreas but aberrantly expressed in pancreatic cancer. In this present study, we identified PSCA expression in islets of the pancreas by immunohistochemistry, which was co-localized with four islet-cell markers: insulin, glucagon, somatostatin and pancreatic polypeptide. In our investigation of the transcription start site of PSCA, we found a non-coding splicing variant of PSCA as well as authentic PSCA transcripts in mRNA samples from a normal pancreas. Both the transcripts were also identified in several pancreatic cancer cell lines. We previously reported that PSCA expression is correlated to the methylation status of the enhancer region in gastric and gallbladder cancer cell lines but not in pancreatic cancer cell lines, suggesting that PSCA expression is regulated in a diff erent mode in pancreatic cancer from that in gastric and gallbladder cancers.
